GLF
MRSN

Groupe la Francaise’s Mersana Therapeutics MRSN Stock Holding History

Groupe la Francaise’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61,488
Closed -$1.78M – 505
2025
Q4 		$1.78M Buy
+61,488
New +$1.17M 0.02% 255

Other funds holding MRSN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Groupe la Francaise's MRSN Position: Q1 2026 in Review

Groupe la Francaise sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 61,488 shares — an estimated $1.78M sold.

Groupe la Francaise first reported a position in MRSN in Q4 2025 and held it in 1 quarter. The position peaked at $1.78M in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

  • Groupe la Francaise reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Groupe la Francaise sold 61,488 Mersana Therapeutics shares in Q1 2026, an estimated $1.78M.
  • Groupe la Francaise first reported a position in Mersana Therapeutics in Q4 2025 and held it in 1 quarter.
  • Groupe la Francaise's Mersana Therapeutics position peaked at $1.78M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.